Herbert S. Chow
Keine laufenden Positionen mehr
Profil
Herbert S.
Chow is the founder of Hemstat, Inc. Prior to founding Hemstat, he worked as the Chief Technology Officer at Stellar Biotechnologies, Inc. from 2012 to 2014.
Chow received his undergraduate degree from The Ohio State University and his doctorate from the University of Illinois.
Ehemalige bekannte Positionen von Herbert S. Chow
| Unternehmen | Position | Ende |
|---|---|---|
Stellar Biotechnologies, Inc.
 Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Technik-/Wissenschafts-/F&E-Leiter | 10.12.2014 |
| Hemstat, Inc. | Gründer | - |
Ausbildung von Herbert S. Chow
| The Ohio State University | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |
| Hemstat, Inc. |
